ResMed | RMD - Capital Ordinário





Capital Ordinário Alterar Data
Ansell USD 142.94M 885.26M 2025-12
Artivion USD 47.84M 468K 2025-12
AtriCure USD 50.64M 7K 2026-06
Baxter International USD 517M 549K 2026-06
Cochlear AUD 65.4M 1.12B 2025-12
Cooper Companies USD 195.11M 14K 2026-03
CSL USD 482.13M 93.87M 2025-12
Dexcom USD 377.4M 8.5M 2026-06
Edwards Lifesciences USD 577M 3.7M 2026-03
Fisher Paykel Healthcare NZD 586.94M 313.22K 2026-06
Globus Medical USD 135.67M 611K 2026-03
Haemonetics USD 45.47M 1.36M 2026-06
Idexx Laboratories USD 78.87M 366K 2026-06
Inogen USD 23K 0 2023-12
Insulet USD 69.35M 87K 2026-06
Integra LifeSciences USD 77.78M 39K 2026-06
Intuitive Surgical USD 354.16M 1.01M 2026-06
Medtronic USD 1.28B 130K 2026-06
Philips EUR 952.02M 729K 2026-03
Ramsay Health Care AUD 229.93M 29.81K 2025-12
ResMed USD 145.06M 45.78M 2026-06
Sigma Healthcare AUD 11.5B 9.93B 2025-12
Sonic Healthcare AUD 4.15B 467K 2024-12
Steris USD 98.07M 72K 2026-03
Teleflex USD 44.26M 70K 2026-03
Thermo Fisher Scientific USD 371.62M 1000 2026-06